Both in Pharmaceuticals
Korro Bio vs Atrium Therapeutics
Over the past year KRRO returned −77.7% and RNA returned −80.2%; their daily moves had a correlation of 0.02.
KRRO −77.7% RNA −80.2%Growth of $1, one year, split-adjusted
| Metric | KRRO | RNA |
|---|---|---|
| Price | $9.56 | $8.42 |
| Market cap | $140.8M | $144.0M |
| Today | +0.53% | 0.00% |
| 1 month | −25.9% | −38.3% |
| 6 months | −7.0% | −37.9% |
| Year to date | +19.4% | −88.3% |
| 1 year | −76.5% | — |
| Revenue growth (YoY) | −100.0% | −21.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −672.0% |
| P/E (TTM) | — | — |
| Price / sales | 59.1× | 4.0× |
| Net cash | $115.0M | $263.9M |
| Dividend yield | — | — |
| Volatility (60d) | 74.5% | 64.4% |
| Short % of float | 13.8% | 20.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).